High Basal Levels of Functional Toll-Like Receptor 3 (TLR3) and Noncanonical Wnt5a Are Expressed in Papillary Thyroid Cancer and Are Coordinately Decreased by Phenylmethimazole Together with Cell Proliferation and Migration
- 1 September 2007
- journal article
- Published by The Endocrine Society in Endocrinology
- Vol. 148 (9) , 4226-4237
Abstract
High basal levels of TLR3 and Wnt5a RNA are present in papillary thyroid carcinoma (PTC) cell lines consistent with their overexpression and colocalization in PTC cells in vivo. This is not the case in thyrocytes from normal tissue and in follicular carcinoma (FC) or anaplastic carcinoma (AC) cells or tissues. The basally expressed TLR3 are functional in PTC cells as evidenced by the ability of double-strand RNA (polyinosine-polycytidylic acid) to significantly increase the activity of transfected NF-kappaB and IFN-beta luciferase reporter genes and the levels of two end products of TLR3 signaling, IFN-beta and CXCL10. Phenylmethimazole (C10), a drug that decreases TLR3 expression and signaling in FRTL-5 thyrocytes, decreases TLR3 levels and signaling in PTC cells in a concentration-dependent manner. C10 also decreased Wnt5a RNA levels coordinate with decreases in TLR3. E-cadherin RNA levels, whose suppression may be associated with high Wnt5a, increased with C10 treatment. C10 simultaneously decreased PTC proliferation and cell migration but had no effect on the growth and migration of FC, AC, or FRTL-5 cells. C10 decreases high basal phosphorylation of Tyr705 and Ser727 on Stat3 in PTC cells and inhibits IL-6-induced Stat3 phosphorylation. IL-6-induced Stat3 phosphorylation is important both in up-regulating Wnt5a levels and in cell growth. In sum, high Wnt5a levels in PTC cells may be related to high TLR3 levels and signaling; and the ability of phenylmethimazole (C10) to decrease growth and migration of PTC cells may be related to its suppressive effect on TLR3 and Wnt5a signaling, particularly Stat3 activation.Keywords
This publication has 73 references indexed in Scilit:
- Overexpression of Wnt-1 in thyrocytes enhances cellular growth but suppresses transcription of the thyroperoxidase gene via different signaling mechanismsJournal of Endocrinology, 2007
- Phosphorylation of β-Catenin by AKT Promotes β-Catenin Transcriptional ActivityJournal of Biological Chemistry, 2007
- Insulin-like Growth Factor-1 (IGF-1) Induces WISP-2/CCN5 via Multiple Molecular Cross-talks and Is Essential for Mitogenic Switch by IGF-1 Axis in Estrogen Receptor–Positive Breast Tumor CellsCancer Research, 2007
- Toll‐like receptor 3 associates with c‐Src tyrosine kinase on endosomes to initiate antiviral signalingThe EMBO Journal, 2006
- Targeting STAT3 affects melanoma on multiple frontsCancer and Metastasis Reviews, 2005
- Reduced STAT3 activity in mice mimics clinical disease syndromesBiochemical and Biophysical Research Communications, 2005
- Tyrosine kinase oncoprotein, RET/PTC3, induces the secretion of myeloid growth and chemotactic factorsOncogene, 2003
- Armadillo/β-catenin signals in the nucleus – proof beyond a reasonable doubt?Nature Cell Biology, 2003
- Guest Editorial: Two Proposals Regarding the Terminology of Thyroid TumorsInternational Journal of Surgical Pathology, 2000
- Expression of the RET/PTC Fusion Gene as a Marker for Papillary Carcinoma in Hashimoto's ThyroiditisThe Laryngoscope, 1997